儿科中枢静脉接入装置相关的并发症成本:系统性审查
Elouise R Comber1, Amanda Ullman1, Stephanie Hall1
1Centre for Children's Health Research, Children's Health Queensland Hospital and Health Service, Queensland, Australia; School of Nursing, Midwifery and Social Work, The University of Queensland, Australia.
The Journal of hospital infection
|November 21, 2025
概括
中枢静脉通道装置 (CVAD) 在重症儿童的并发症是昂贵的,从3,684美元到超过378,000美元. 传染性并发症显著推动了儿童医院护理中的这些费用.
科学领域:
- 医学经济学 医学经济学
- 儿科重症监护 儿科重症监护
- 医疗保健服务研究 医疗服务研究
背景情况:
- 重症儿科患者经常需要中央静脉接入装置 (CVAD) 来进行医疗手术.
- 复发性静脉动脉器最大限度地降低了重复静脉穿刺的风险,但与严重的传染性和非传染性并发症有关.
- 这些并发症导致医院环境中的大量临床和经济负担.
研究的目的:
- 确定儿童医院护理中中枢静脉接入装置相关并发症的平均成本.
- 调查临床和卫生服务因素如何影响这些并发症的成本变化.
主要方法:
- 根据PRISMA指南进行了系统审查.
- 在EMBASE,CINAHL,PubMed,Web of Science,Cochrane Library (CENTRAL) 和EconLit数据库中对2012年1月至2025年1月期间发表的研究进行了搜索.
- 从3,932项研究的初始搜索中,包括了22项研究.
主要成果:
- 与CVAD相关的并发症成本差异很大,从3,684.32美元到378,288.81美元 (2024美元),受并发症类型,医院环境和国家的影响.
- 观察到很高的异质性,可能是由于估计中包含的不同成本组件.
- 对成本计算方法的报道很少,只有一个研究详细介绍了其方法.
结论:
- 中枢静脉接入装置的并发症,尤其是传染性并发症,在儿科重症监护中代表着巨大的财务负担.
- 广泛的成本范围和异质性凸显了对标准化成本估计方法的需求.
- 需要进一步的研究,以了解和减轻CVAD并发症对儿童的经济影响.
相关概念视频
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
702
Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
702
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
498
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
498
Hemodialysis II: Procedure and Complications
583
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
583
Endocarditis IV: Nursing Management
305
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
305
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
232
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
232
Pharmacokinetics in Pediatric Patients: Drug Distribution
247
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
247


